Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 14;10(1):86-93.
doi: 10.1002/mdc3.13584. eCollection 2023 Jan.

Gender Differences in the Prevalence of Parkinson's Disease

Affiliations

Gender Differences in the Prevalence of Parkinson's Disease

Alexandra Zirra et al. Mov Disord Clin Pract. .

Abstract

Background: Parkinson's disease (PD) affects males more than females. The reasons for the gender differences in PD prevalence remain unclear.

Objective: The objective of this systematic review and meta-analysis was to update the overall male/female prevalence ratios (OPR).

Methods: We updated previous work by searching MEDLINE, SCOPUS, and OVID for articles reporting PD prevalence for both genders between 2011 and 2021. We calculated OPRs and investigated heterogeneity in effect estimates.

Results: We included 19 new articles and 13 articles from a previously published meta-analysis. The OPR was 1.18, 95% CI, [1.03, 1.36]. The OPR was lowest in Asia and appeared to be decreasing over time. Study design, national wealth, and participant age did not explain OPR heterogeneity.

Conclusion: Gender differences in PD prevalence may not be as stark as previously thought. Studies are needed to understand the role of other determinants of gender differences in PD prevalence.

Keywords: Parkinson's disease; gender differences.; meta‐analysis; prevalence; systematic review.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
PRISMA flow diagram of article selection and final count of articles selected. (A) Results from search strategy. (B) Final results from the search strategy included 19 articles from 2011 to 2021. These were added to the list of articles from Pringsheim et al, totaling 32 articles from the years 1985 to 2021
FIG. 2
FIG. 2
Subgroup meta‐analysis using random effects model for each study continent in the male/female (M/F) prevalence ratio. Random effects meta‐analysis with Cochrane Q statistic of the overall M/F prevalence ratio of each study categorized by its respective continent. The pooled prevalence ratio for all the studies was 1.18, 95% CI, [1.03, 1.36], but heterogeneity was high between groups (I = 99.8%, P = 0.013).

References

    1. Dorsey ER, Bloem BR. The Parkinson pandemic‐a call to action. JAMA Neurol 2018;75:9–10. - PubMed
    1. GBD 2016 Parkinson's Disease Collaborators . Global, regional, and national burden of Parkinson's disease, 1990–2016: A systematic analysis for the global burden of disease study 2016. Lancet Neurol 2018;17:939–953. - PMC - PubMed
    1. Pringsheim T, Jette N, Frolkis A, Steeves TDL. The prevalence of Parkinson's disease: A systematic review and meta‐analysis. Mov Disord 2014;29:1583–1590. - PubMed
    1. Ma C‐L, Su L, Xie JJ, Long JX, Wu P, Gu L. The prevalence and incidence of Parkinson's disease in China: A systematic review and meta‐analysis. J Neural Transm 2014;121:123–134. - PubMed
    1. Riccò M et al. Prevalence of Parkinson disease in Italy: A systematic review and meta‐analysis. Acta Biomed 2020;91:e2020088. - PMC - PubMed

LinkOut - more resources